Psoriasis Therapy can Reduce Coronary Inflammation
Psoriasis therapy reduces coronary inflammation, which can be measured by an imaging biomarker called perivascular fat attenuation index (FAI). Psoriasis therapy appreciably reduces the risk of fatal cardiac events such as heart attack and stroke.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer